30 Day Trial

NuVasive Up 3.7% on US Spinal Hardware in 2Q19

Share:

NuVasive posts 2Q19 revenue of USD $292.1MM, +3.7% vs. 2Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.